Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.
Cidara Therapeutics develops targeted immunotherapies aimed at improving treatment outcomes for patients with serious diseases.
IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.
Semnur Pharmaceuticals is a specialty pharmaceutical company focusing on clinical and commercial development of innovative products.
Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.
Ronovo Surgical is an emerging medtech company focused on innovating minimally invasive (MIS) and digital surgery.
Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.
Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.
ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.
Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.
Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.
Aligos Therapeutics is discovering and developing new classes of molecules that interact directly with disease-causing modalities.
ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.
Neumirna Therapeutics is a pharmaceutical company that develops therapeutics for the treatment of neurological diseases.
Chentai New Materials integrates the R&D, design, manufacturing, and sales of high-performance composite ceramics.
35Pharma is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need.
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.
Serán Bioscience is a contract development and manufacturing organization.
Lepu Bio is a Innovation-Driven Biopharmaceutical Company offering unmet medical needs of cancer patients with best-in-class drugs.
Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.
Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system.
Vivo Capital has invested in 167 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Vivo Capital's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Therapeutics, Biopharma. The firm invests across 18 different industry categories.
Among tracked funding rounds, Celcuity received $500.0M in a Post Ipo Debt round. Vivo Capital's total known invested capital is $11.0B.
Vivo Capital's average investment size is $97.8M across its portfolio of 167 companies.
Recent Vivo Capital portfolio additions include Biohaven Pharmaceutical, Zenas BioPharma, Cidara Therapeutics, IO Biotech, Semnur Pharmaceuticals. These companies were founded in 2020 or later.